The American Cancer Society estimates that 12,850 Florida residents will be diagnosed with colorectal cancer in 2026, and ...
And how you can lower the risk of one of the most deadly cancers by 69%.
Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.
For patients with colorectal cancer, surgery can remove visible cancer, but it can be difficult to know whether minute traces of the disease remain. Abbott (NYSE: ABT) today announced new Beta-CORRECT ...
Good morning!This time, it is about what you need to know for your first colonoscopy.1. Money (it costs quite a bit)If you ...
A multi-stage virtual screening campaign against the c-Myc/Max dimerization interface has identified two small molecules that ...
Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...
Summit Therapeutics Inc. (NASDAQ: SMMT) and Lunit Inc. (KRX: 328130) today announced a research agreement to evaluate the use ...
In 2022, the proportion of eligible U.S. adults screened for lung cancer was lower than the proportions screened for breast ...
On Friday, Abbott ( ABT) said its whole-genome sequencing-based Oncodetect test showed a 30-percentage-point improvement in sensitivity for colorectal cancer recurrence within two years of surgery ...
Newspoint on MSN
Don't ignore these toilet warning signs! Symptoms mistaken for piles could point to colorectal cancer
Bleeding during bowel movements, persistent constipation and sudden changes in toilet habits are problems many people tend to ...
A FAIR²-certified dataset from a single Chinese hospital documents mismatch repair and microsatellite instability status, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results